| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -38.91M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CADL returned +120.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +132.4% |
| 1 year | +120.7% |
| 5 years | +63.3% |
| All-time high | $13.13 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CADL would be worth today ›No. Candel Therapeutics, Inc. has not paid a dividend in the past 12 months.
Candel Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol CADL.
Candel Therapeutics, Inc. is part of the Healthcare sector.
Candel Therapeutics, Inc. has a market cap of 1.00B USD, based on the latest quote.
Candel Therapeutics, Inc. is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
